|
First author (Reference No.)
|
Number of patients
|
Total dose (Gy)
|
Single dose (Gy/fraction)
|
BED10 (Gy)
|
Median follow up (months)
|
Local control (%)**
|
3-year overall survival (%)
|
|---|
|
Timmerman[6]
|
55
|
60
|
20
|
180
|
34.4
|
98.2
|
55.8
|
|
Nagata[5]*
|
42
|
48
|
12
|
105.6
|
30
|
97.8
|
83
|
|
Fakiris[7]
|
70
|
60, 66
|
20, 22
|
180 - 211.2
|
50.2
|
94.3
|
42.7
|
|
Onishi[3]*
|
257
|
18 - 75
|
4.4 - 35
|
57.6 - 180
|
38
|
88.7
|
56.8
|
|
Our results*
|
80
|
48 - 60
|
4 – 12
|
84 – 105.6
|
30.4
|
92.5
|
89.9
|
- BED10 is biological effective dose (BED) calculated from prescribed dose.
- * Dose is calculated at the iso-center.
- **Local control (%) = (number of patients without local recurrence) / (number of all patients)×100.
